Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | INCA32459 |
Trade Name | |
Synonyms | INCA 32459|INCA-32459 |
Drug Descriptions |
INCA32459 is a bispecific antibody that targets both PD-1 (PDCD1) and LAG3, potentially leading to increased antitumor immune response and inhibition of tumor growth (Journal for ImmunoTherapy of Cancer 2022;10). |
DrugClasses | LAG3 Antibody 18 PD-L1/PD-1 antibody 121 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
INCA32459 | INCA32459 | 0 | 1 |